SunRegen Healthcare AG
New drug development for neurodegenerative diseases
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
20.08.2024
SunRegen Healthcare to go public via reverse takeover (startupticker.ch)
19.05.2020
Eleven Swiss start-ups on the virtual BIO Digital stage (startupticker.ch)
04.10.2019
A new cohort joins the BaseLaunch accelerator (startupticker.ch)
15.11.2018
SunRegen wins international biotech startup competition (startupticker.ch)
30.10.2017
No Jobs
No videos and documents
No Awards
SunRegen Healthcare AG
New drug development for neurodegenerative diseases
Website:
www.sunregen.ch
Headquarter:
Reinach
Foundation Date:
March 2017
Sectors:
- Neurology